Keywords: morphotek, licenses, cancer, ab, hmi, subsidiary, japan

Morphotek licenses cancer Ab from HMI

Article | 17 March 2008

Print This

Morphotek, a US subsidiary of Japan's Eisai, has signed a licensing deal with Human Monoclonals International for rights to a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in